|
|
|||
Rett syndrome is an X-linked neurodevelopmental
disorder caused by mutations in the MECP2 gene which encodes
the Methyl CpG Binding Protein 2 transcriptional repressor. Rett syndrome
affects ~1 in 10,000 females with symptoms including loss of speech and
purposeful hand use, microcephaly, seizures, ataxia, and stereotypic
hand movements. MECP2 mutations
manifest a broader spectrum of clinical phenotypes in female and rare male
patients, with features overlapping with other mental retardation disorders.
Mutations in the MECP2 coding region can be detected by sequence
analysis in up to ~85% of Rett cases. Our laboratory offers DNA sequencing
analysis of MECP2 exons 1 through 4. Reasons for Referral:
Testing Methodology:DNA Sequencing of MECP2 exons 1 through 4 in both directions using a 96-capillary sequencer. Sensitivity:Sequencing has an analytical sensitivity of ~99% for point mutations. Up to ~85% of classic Rett patients have MECP2 gene mutations that can be identified by sequencing. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 14
cc; Child: 6
cc; Infant: 6 cc Turnaround Time:3 weeks CPT Codes and Prices:Index: 83904x7, 83912, 83909x14,
83898x10, 83894, 83891 References:1. Amir R, et al. (1999) Nat. Genet. 23: 185-188. Shipping InformationForms: >> Gene
Sequencing Requisition Test Codes:Index: 6068 |